ARCHIVES

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Director To Decide Fate Of P-4 After NCAB Meeting In June.

April 20, 2007

FDA Advisors Recommend Use of Cytokines GM-CSF, G-CSF In BMT And Chemotherapy

January 4, 1991

Oncology Nurse “Cinderella’s” Need Specialty Status

November 23, 1974

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

IOM Committee Focuses on Studies Needed To Protect Patients On Omics-Based Trials

November 4, 2011

Congress Passes Unprecedented 15% Increase For NIH On Last Day Of Session

October 23, 1998